Literature DB >> 12377951

The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1.

Lena Svensson1, Claes Dahlgren, Christine Wennerås.   

Abstract

Whereas prokaryotes use L- and D-isomers of amino acids in their protein synthesis, eukaryotic proteins as a rule incorporate only L-isomers. Hence, D-isomers may constitute danger signals to the innate immune system. A D-methionine-containing peptide, Trp-Lys-Tyr-Met-Val-D-Met-NH(2) (WKYMVm), has been shown to be a stronger activator of neutrophils than f-Met-Leu-Phe. The aim of this study was to compare the responsiveness of eosinophils to WKYMVm with that of neutrophils. The peptide was found to induce chemotaxis and respiratory burst in eosinophils. However, it did not mobilize granule constituents, as evidenced by a lack of eosinophil cationic protein, eosinophil peroxidase, and interleukin-5 in the supernatants of stimulated eosinophils. In contrast, WKYMVm caused the release of complement receptor 3 from secretory vesicles in neutrophils. Different members of the formyl peptide receptor family were preferentially engaged by the peptide in the two classes of granulocytes: the formyl peptide receptor itself in eosinophils and formyl peptide receptor-like 1 in neutrophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377951

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.

Authors:  Anne M Brooks; Mary Ellen Bates; Rose F Vrtis; Nizar N Jarjour; Paul J Bertics; Julie B Sedgwick
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-25       Impact factor: 6.914

2.  Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells.

Authors:  Christine Lingblom; Henrik Bergquist; Marianne Johnsson; Patrik Sundström; Marianne Quiding-Järbrink; Mogens Bove; Christine Wennerås
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

3.  Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Anya J Cutler; Molly S Kidder; Tao Liu; Juan Carlos Cardet; Heng Chhay; Chunli Feng; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

4.  Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils.

Authors:  Mary Ellen Bates; Julie B Sedgwick; Yiming Zhu; Lin Ying Liu; Rose G Heuser; Nizar N Jarjour; Hirohito Kita; Paul J Bertics
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

5.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.

Authors:  Anna-Lena Stenfeldt; Christine Wennerås
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.